A new research indicated “an implantable pacemaker-like device that controls breathing muscles during sleep by electrical stimulation of a phrenic nerve proved effective in patients with moderate to severe central sleep apnea.”
Investigators found that “phrenic nerve stimulation with the remedē System (Respicardia Inc) led to significant reductions in central apnea index (CAI), hypoxia, arousals, improved sleep quality, and overall quality of life and was safe.” The findings were presented at SLEEP 2016: 30th Anniversary Meeting of the Associated Professional Sleep Societies.